Anomaly® aminogel: silicone-free amino-acid oil gelator for cosmetics
Anomaly® AminoGel is a silicone-free amino-acid oil gelator that transforms liquid emollients into clear gels at low concentrations. It offers improved glide, reduced greasiness, and is ideal for anhydrous cosmetic formulations such as serums and balms.
Overview
Anomaly® AminoGel is a novel silicone-free amino-acid oil gelator designed to enhance anhydrous and oil-rich cosmetic formulations. It effectively transforms liquid emollients into clear or translucent gels with a controlled rheology, offering an elegant skin feel. This innovative gelator allows for the creation of products with a smooth glide and reduced greasiness, comparable to traditional polyamide and silicone-based thickeners. It is particularly suited for leave-on applications such as serums, primers, balms, and stick systems.
Technical specifications
Anomaly® AminoGel operates at low concentrations of 1–5%, where it self-assembles into a three-dimensional fibrous network within oil phases. This structure provides yield stress, thixotropy, and excellent suspension stability while maintaining optical clarity. It is processable at temperatures of 80–90°C, ensuring compatibility with scalable production processes. The gelator meets commercial supply standards and regulatory documentation requirements, making it a practical choice for cosmetic product developers.
Technology readiness level
Anomaly® AminoGel has reached Technology Readiness Level 9, indicating it is fully validated and ready for commercial deployment. It is available for immediate supply, with laboratory-scale samples offered for evaluation and formulation trials. Technical documentation, including Certificates of Analysis and Safety Data Sheets, are available to support product assessment.
About Anomaly Bio
Anomaly Bio is a Singapore-based biotechnology company that utilizes synthetic biology, advanced fermentation, and strain engineering to produce bio-based ingredients. By designing optimized metabolic pathways, the company engineers microorganisms to transform readily available feedstocks, such as sugars, into high-value molecules. This approach turns microbes into efficient micro-factories, offering a scalable and on-demand alternative to traditional, extraction-based manufacturing methods. The company focuses on developing next-generation inputs for industries including crop protection, nutrition, and personal care.
By replacing fragile, legacy supply chains with localized and resilient biomanufacturing capabilities, Anomaly Bio aims to redefine the production of essential ingredients. This technology provides a viable, sustainable manufacturing solution that can be deployed globally to support various trade networks. The company has secured significant pre-seed funding to expand its R&D team in metabolic engineering and to establish its own laboratory and pilot-scale production facilities in Singapore.
delivered to your inbox.